Purdue’s Oxycontin Targeted at Judge’s Opioid Summit

February 2, 2018

(Bloomberg) – Local governments pressing lawsuits to hold pharmaceutical companies responsible for the opioid epidemic told a judge that taking the strongest version of Purdue Pharma Inc.’s Oxycontin painkiller off the market would have immediate results in addressing the crisis, according to people at the meeting. Purdue’s 80-milligram version of Oxycontin is snorted by thousands of abusers, so removing it would be a good first step, experts for cities and counties and state attorneys general told U.S. District Judge Dan Polster, according to three people in attendance at the Wednesday meeting.

Posted by

Posted in News, Pharma, Public Health

Recommended Reading